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ABSTRACT
Gestational diabetes mellitus (GDM) is a
medical as well as obstetric challenge, which
needs person-centered management. The
timing of delivery of women with GDM is
discussed by various obstetric professional
bodies. We highlight pertinent medical,
obstetric, and psychosocial factors which may
influence the timing of delivery in women with
GDM. This commentary proposes a
person-centered approach to decide the
delivery timing in GDM and supports shared
decision-making based upon the individual’s
biopsychosocial characteristics and
environmental factors.
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INTRODUCTION
The prevalence of gestational diabetes mellitus
(GDM) is rapidly increasing across the world
and it is a common endocrine complication in
obstetric practice today [1–3]. GDM, as a
syndrome, is marked by controversy related to
virtually every facet, ranging from its
nomenclature, screening tools, and diagnosis
to management strategies [4, 5]. Most debate on
GDM management centers on medical issues,
such as appropriateness of oral hypoglycemic
agents. In this communication, we discuss the
timing of delivery in GDM and emphasize the
need for person-centered, shared
decision-making in this regard.
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CURRENT RECOMMENDATIONS
Expert recommendations suggest that women
with uncomplicated GDM take their
pregnancies to term, and deliver at 38 weeks
gestation [6]. Such a decision is not as simple as
it seems. These recommendations differ from
earlier findings, which suggested earlier
induction of labor [7], but are consonant with
secular trends in obstetrics, which support
longer periods of gestation. Guidelines also
state that GDM per se is not a factor in
determining mode of delivery [6, 8].
The American College of Obstetricians and
Gynecologists and the Society for Maternal
Fetal Medicine have proposed new
recommendations for terminology of
gestational age and delivery timing [6]. For
women with well-controlled diabetes, whether
pregestational or gestational, a late preterm or
early term birth, i.e., before 39 completed
weeks of gestation, is not indicated. In a
setting of poorly controlled diabetes, an
individualized decision aiming for late
preterm or early term delivery (before
38 weeks ? 6 days gestation) is recommended.
An early term or term delivery
(38–39 weeks ? 6 days gestation) is suggested
if vascular complications are present in women
with pregestational diabetes. In practice,
however, these gestational ages may be
difficult to attain. It must also be remembered
that these recommendations assume 24/7
availability, accessibility, and affordability of
optimal maternal and fetal monitoring,
including seven-point glycemic profiles and
regular cardiotocography for all women with
GDM. They also take certain attributes of
physical environment, such as ease of travel
and communication, for granted.
PERSON-SPECIFIC ATTRIBUTES
OF GDM
GDM, however, is not a homogenous entity.
Each woman with GDM faces unique challenges
with respect to her ethnicity, biomedical
condition, psychological makeup, and social
support system [9]. These factors influence
postpartum health as well [10]. All these
factors may potentially impact obstetric
decision-making. While robust guidelines are
available to help such decision-making [6, 11],
the quality of many guidelines needs to be
improved. There is discrepancy regarding
induction of labor [12]. There is, therefore, a
need to revisit the factors which may determine
the timing of delivery. These obstetric,
biomedical, and psychosocial factors influence
the course of pregnancy complicated by
diabetes and inform decision-making related
to mode and timing of delivery (Table 1). We
highlight some of these factors in the following
paragraphs.
BIOMEDICAL FACTORS
The obstetrician considers many obstetric and
medical factors while planning the delivery in a
woman with GDM. These are listed in Table 1.
Some of these factors play a role in
decision-making for all deliveries, irrespective
of the presence of diabetes. Certain issues,
however, merit greater attention in women
with GDM.
In general, waiting at least until 38
completed weeks’ gestation improves fetal
outcome, especially in diabetic patients [13].
However, if an indication for early delivery
exists, GDM should not be considered as a
contraindication to proceed with interventions
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for early delivery. Also, if a spontaneous
preterm delivery seems imminent, it should
not be postponed [14]. At times, in fact, an
early, planned operative delivery may be
appropriate for women with ketosis or
ketoacidosis [15], difficult-to-control diabetes,
with frequent episodes of hypoglycemia or
hyperglycemia, excessively high insulin
requirements, or any other clinical situation
which may put the fetus at risk [16]. This may
also be true for women with compromised
cardiovascular, renal, or retinal function.
Macrosomia is a common accompaniment of
GDM, especially in women with uncontrolled
glycemia [16]. The risk of cephalopelvic
disproportion (CPD) and shoulder dystocia
increases as fetal weight gain occurs with
advancing gestational age. The chances of a
normal vaginal delivery, therefore, may recede
as gestation progresses in women with
refractory GDM, or in women on excessively
high doses of insulin. In non-diabetic women,
induction of labor for suspected macrosomia, at
39 weeks gestation, has been found to be
Table 1 Factors inﬂuencing timing of delivery in GDM






H/o previous pregnancy loss
H/o previous IUD at term
H/o macrosomia
H/o previous caesarian sections
No bad obstetric history
Current obstetric
factors
H/o loss of fetal movement











Patient request for early LSCS Patient reluctance for early delivery
Social factors Availability of neonatology care
Ability to provide ACS coverage
Inability to come for frequent follow-up
Patient having to travel long distance for
obstetric/medical care
Lack of specialist neonatology care
Inability to provide ACS coverage
Geographic proximity of health-care facility
Ability to travel comfortably and safely for
obstetric follow-up
GDM gestational diabetes mellitus, IUGR intrauterine growth retardation, LSCS lower segment caesarian section, ACS
antenatal corticosteroid therapy, H/o history of
Diabetes Ther (2016) 7:169–174 171
cost-effective [17] in reducing maternal
complications.
PSYCHOSOCIAL FACTORS
This issue is important in cultures where a
premium is placed upon a woman’s ability to
have normal childbirth, where the parturient is
unable to afford the physical rest required after
surgical delivery, or if the financial burden
associated with an operative delivery has to be
paid by the patient. These realities imply that an
earlier, planneddelivery, at 36–37 weeks gestation,
maybe indicated in selectwomenwithGDM,who
wish to try andmaximize the chances of a normal
vaginal delivery. Induction of labor at less than
40 weeksgestation inwomenwithmildGDMdoes
not increase the risk of LSCS [18]. In fact, the risk of
LSCS rises threefold in women who are induced at
41 weeks, as compared to thosewhoare induced at
39 weeks [18].
ENVIRONMENTAL FACTORS
Apart from the psychosocial factors discussed
above, other external determinants play a role
in deciding the timing of delivery. Availability
of medical support (needed to manage glycemia
after antenatal corticosteroid (ACS) therapy), of
facilities and expertise for assisted vaginal
delivery (ventouse, forceps), of facilities for
operative delivery (including anesthesiology),
and of neonatal care influence the choice of
timing and mode of delivery. Lack of
neonatology or medicine expertise supports a
decision to continue women with GDM to
term, rather than risk a clinical situation
where the mother, with iatrogenic
hyperglycemia secondary to ACS, or the
preterm neonate, delivered by induced labor,
cannot be managed.
The distance that a woman with GDM has to
travel to access health care, the ease with which
the journey is negotiated, and the feasibility of
regular frequent follow-up also influence the
mode and timing of delivery. Early induction of
labor may be appropriate for women who find it
difficult or expensive to travel repeatedly to the
health-care center, for whom travel is
uncomfortable or fraught with physical risk, or
who are unable to adhere to the recommended
frequency of follow-up. While we understand
that these scenarios may seem implausible to
many readers, they are the reality for people
living with diabetes in many parts of the world
[19, 20].
SHARED DECISION-MAKING
Decision regarding the mode and timing of
delivery is a major challenge in routine obstetric
care. This is especially true for women with
GDM. The nature of the condition is such that it
is challenging to conduct randomized
controlled trials to assess the impact of the
mode and timing of delivery on fetomaternal
health. One must rely upon observational data,
experience, and ‘‘good clinical sense’’ to decide
the optimal method of delivery. The
biopsychosocial model [21], coupled with
shared decision-making, provides a useful
framework to help solve this clinical dilemma.
The patient, and her family, including
husband and mother-in-law [20], should be
counseled about the potential benefits and
harms of early (prior to 39 weeks gestation)
and delayed delivery. Her views and preferences
must be ascertained and appropriate decisions
taken. Input from other medical professionals,
who are an integral part of the GDM care team,
should also be considered. Anticipated baby
weight and placental maturity, determined by
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the radiologist; Bishop’s score, calculated by the
obstetrician or midwife; maternal and family
attitudes towards caesarian section, ascertained
by the diabetes educator or psychologist; and
suitability or risk stratification for anesthesia
must all be taken into account while planning
the time of delivery (Table 1).
It must be remembered, though, that in all
decision-making, maternal and fetal safety
come first. Shared decision-making can be
considered in situations characterized by
clinical equipoise, where more than one
therapeutic option is available [22]. For
example, a woman with GDM, with a good
sized baby ([4000 g weight) [23]) on abdominal
or ultrasonographic examination, presenting at
37–38 weeks with a history of recent weight
gain, and favorable cervical findings on per
vaginum examination may be given the option
of induction of labor. On the other hand, a
scenario with maternal distress or fetal distress
leaves no room for prevarication: informed
consent for labor induction is absolutely
necessary to ensure maternal and fetal
well-being.
CONCLUSION
The timing of delivery in GDM is an important
decision,which should be taken keeping inmind
the biomedical, psychological, social, and
environmental factors operating in the
particular person. Such a decision is best arrived
at through a process of active, informed
discussion with the patient and her family.
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